Results 11 to 20 of about 313,454 (314)

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

open access: yesACS Medicinal Chemistry Letters, 2020
While remdesivir has garnered much hope for its moderate anti-Covid-19 effects, its parent nucleoside, GS-441524, has been overlooked. Pharmacokinetic analysis of remdesivir evidences premature serum hydrolysis to GS-441524; GS-441524 is the predominant ...
Victoria C. Yan, F. Muller
semanticscholar   +1 more source

1H-NMR SPECTROSCOPY TO MEASURE THE KI INDEX OF BOMBAY DUCKS DURING CHILLING STORAGE AS AN APPROACH TO DETERMINE FRESHNESS

open access: yesSqualen, 2023
The quality of fish freshness plays a crucial role in the acceptance of consumers and human health. Considering that food safety has recently become a major concern on a global scale, establishing and evaluating fish freshness is crucial for research and
Giri Rohmad Barokah   +3 more
doaj   +1 more source

Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents

open access: yesPharmaceuticals, 2022
Coronavirus disease 2019 (COVID-19) is an emerging global pandemic with severe morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Franck Amblard   +11 more
doaj   +1 more source

Purine nucleoside phosphorylase deficiency

open access: yesAtlas of Inherited Metabolic Diseases, 2020
People with purine nucleoside phosphorylase deficiency have low numbers of immune system cells called T cells, which normally recognize and attack foreign invaders to prevent infection.
C. Staufner
semanticscholar   +1 more source

New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections

open access: yesChemistry - An Asian Journal, 2019
Eight different compounds, all nucleoside analogues, could presently be considered as potential drug candidates for the treatment of Ebola virus (EBOV) and/or other hemorrhagic fever virus (HFV) infections.
E. De Clercq
semanticscholar   +2 more sources

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression [PDF]

open access: yes, 2002
This study evaluated 1433 human immunodeficiency virus (HIV)-infected patients starting highly active antiretroviral therapy (HAART), 409 (28%) of whom had prior nucleoside experience and achieved an HIV load of
Bickel, M   +11 more
core   +1 more source

Zika virus protection by a single low dose nucleoside modified mRNA vaccination

open access: yesNature, 2017
Zika virus (ZIKV) has recently emerged as a pandemic associated with severe neuropathology in newborns and adults. There are no ZIKV-specific treatments or preventatives.
N. Pardi   +36 more
semanticscholar   +1 more source

Phosphorylation of purine and pyrimidine nucleosides by isolated rat liver mitochondria [PDF]

open access: yes, 1975
Formation of 5'-AMP, 5'-GMP, 5'-CMP and 5'UMP was confirmed in isolated rat liver mitochondria incubated with alpha-ketoglutarate, inorganic phosphate, purine nucleoside and pyrimidine nucleoside. Increased incorporation of 32Pi into ATP, GTP and UTP was
Inaba, Kozo, Oda, Takuzo
core   +1 more source

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

open access: yesNew England Journal of Medicine, 1997
BACKGROUND The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear.
S. Hammer   +17 more
semanticscholar   +1 more source

Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues

open access: yesMolecules, 2020
Nucleoside analogues have proven to be highly successful chemotherapeutic agents in the treatment of a wide variety of cancers. Several such compounds, including gemcitabine and cytarabine, are the go-to option in first-line treatments.
Mieke Guinan   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy